临床外科杂志 ›› 2023, Vol. 31 ›› Issue (8): 738-741.doi: 10.3969/j.issn.1005-6483.2023.08.011

• 论著 • 上一篇    下一篇

青蒿素通过TLR4/NF-κB信号通路调节胃癌细胞的生长和炎症因子分泌的机制研究

  

  1. 056000   河北省邯郸市第一医院消化一科(马立东);河北省邯郸市第一医院老年病一科(刘晓蕾);河北省优抚医院消化科 (赵飞)
  • 收稿日期:2022-10-17 修回日期:2022-10-17 接受日期:2022-10-17 出版日期:2023-08-25 发布日期:2023-08-25
  • 基金资助:
    河北省医学科学课题研究计划项目(20220491)

Study on the mechanism of artemisinin regulating the growth of gastric cancer cells and the secretion of inflammatory factors through the TLR4/NF-κB signaling pathway

  1. Department of Gastroenterology,the First Hospital of Handan,Hebei province,Handan 056000,China
  • Received:2022-10-17 Revised:2022-10-17 Accepted:2022-10-17 Online:2023-08-25 Published:2023-08-25

摘要: 目的 研究青蒿素是否通过Toll样受体4(TLR4)/核转录因子κB(NF-κB)信号通路调节胃癌细胞的增殖、凋亡和炎症因子分泌。方法 将胃癌AGS细胞分为对照(NC)组、50-μmol/L青蒿素组、100μmol/L青蒿素组、200μmol/L青蒿素组和pcDNA+200μmol/L青蒿素组、pcDNA-TLR4+200μmol/L青蒿素组。给予青蒿素处理后,CCK-8法检测细胞增殖活性,流式细胞术检测细胞凋亡,Western blot检测细胞周期蛋白D1(CyclinD1)、活化的含半胱氨酸的天冬氨酸蛋白水解酶3(Cleaved-caspase-3)、TLR4、p-p65、p65水平,酶联免疫吸附测定法(ELISA)检测肿瘤坏死因子α(TNF-α)、白细胞介素(IL)6和IL-1β炎症因子的表达,RT-qPCR检测TLR4 mRNA表达。结果 与NC组比较,50μmol/L青蒿素组、100μmol/L青蒿素组、200μmol/L青蒿素组AGS细胞增殖活性、CyclinD1蛋白、TNF-α、IL-6、IL-1β、TLR4 mRNA、TLR4蛋白的表达水平和p-p65/p65比值均降低,凋亡率和Cleaved-caspase-3水平升高,并且不同浓度青蒿素组与NC组之间差异有统计学意义(P<0.05);200μmol/L青蒿素组AGS细胞中p-p65/p65比值比NC组低,差异有统计学意义(P<0.05)。与pcDNA+200μmol/L青蒿素组比较,pcDNA-TLR4+200μmol/L青蒿素组AGS细胞中TLR4 mRNA的表达水平、增殖活性、CyclinD1蛋白、TNF-α、IL-6、IL-1β和p-p65/p65比值均升高,凋亡率和Cleaved-caspase-3水平降低,并且两组之间差异有统计学意义(P<0.05)。结论 青蒿素通过下调TLR4/NF-κB信号通路,从而抑制胃癌细胞的增殖活性和炎症因子分泌,并促进凋亡。

关键词: 胃癌, 青蒿素, TLR4, NF-κB信号通路, 炎症, 增殖, 凋亡

Abstract: Objective  To investigate whether artemisinin regulates the proliferation,apoptosis and secretion of inflammatory factors in gastric cancer cells through the Toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) signaling pathway.Methods Gastric cancer AGS cells were divided into control (NC) group,50μmol/L artemisinin group,100μmol/L artemisinin group,200μmol/L artemisinin group,pcDNA+200μmol/L artemisinin group and pcDNA-TLR4+200μmol/L artemisinin group.After the treatment,CCK-8 method was performed to detect cell proliferation activity,flow cytometry was used to measure cell apoptosis,cyclin D1 (CyclinD1),activated cysteine-containing aspartate proteolytic enzyme-3 (Cleaved-caspase-3),TLR4,p-p65,and p65 levels were detected by Western blot.The expression of tumor necrosis factor-α (TNF-α),interleukin (IL)-6 and IL-1β inflammatory factors were tested by enzyme-linked immunosorbent assay (ELISA),and the expression of TLR4 mRNA was detected by RT-qPCR.Results Compared with the NC group,the AGS cell proliferation activity,the expression levels of CyclinD1 protein,TNF-α,IL-6,IL-1β,TLR4 mRNA,TLR4 protein and p-p65/p65 ratio decreased in 50-μmol/L artemisinin group,100μmol/L artemisinin group and 200μmol/L artemisinin group.The apoptosis rate and Cleaved-caspase-3 level increased,and there was a statistically significant difference between the artemisinin group and the NC group at different concentrations (P<0.05).The ratio of p-p65/p65 in AGS cells in the 200 μmol/L artemisinin group was lower than that in the NC group,and the difference was statistically significant (P<0.05).Compared with the pcDNA+200 μmol/L artemisinin group,the expression level of TLR4 mRNA,proliferation activity,the expression level of CyclinD1 protein,TNF-α,IL-6,IL-1β and p-p65/p65 ratio in AGS cells in the pcDNA-TLR4+200 μmol/L artemisinin group increased,the apoptosis rate and the level of Cleaved-caspase-3 decreased,and the difference between the two groups was statistically significant (P<0.05).Conclusion Artemisinin inhibits the proliferation activity and inflammatory factor secretion of gastric cancer cells by down-regulating the TLR4/NF-κB signaling pathway,and promotes apoptosis.

Key words: gastric cancer, artemisinin, TLR4, NF-κB signaling pathway, inflammation, proliferation, apoptosis

[1] 彭建明 徐卫东 罗玉根 董圳. 血小板与淋巴细胞比值联合全身炎症反应指数对非肌层浸润性膀胱肿瘤等离子电切术后复发的预测价值[J]. 临床外科杂志, 2023, 31(7): 673-676.
[2] 刘宇 眭超 陶亮 王萌. 胃肠道术后延迟性肠麻痹研究进展[J]. 临床外科杂志, 2023, 31(7): 698-700.
[3] 曾强 张宇 陈辉 石珂 周丽. 富含亮氨酸的α2糖蛋白1通过RUNX1/OPN信号调节非小细胞肺癌细胞的增殖、迁移和侵袭 [J]. 临床外科杂志, 2023, 31(6): 562-567.
[4] 熊祥云 丁佑铭 苏洋. 术前炎症指标预测肝移植术后感染的价值[J]. 临床外科杂志, 2023, 31(5): 457-460.
[5] 顾杰 李杜渐 李权 李尧. 全身免疫炎症指数预测上尿路结石术后尿脓毒血症发生的列线图模型[J]. 临床外科杂志, 2023, 31(5): 470-474.
[6] 张天翼 高杨 马尧 任明智 王孝彬 马骏. LINC01197调控Notch通路促进肺腺癌细胞增殖和侵袭[J]. 临床外科杂志, 2023, 31(4): 335-339.
[7] 徐慧 李昊 秦静静 柳涛涛 谢昌奇 张曹. 术前血浆纤维蛋白原与非转移性胃癌病人预后关系的Meta分析[J]. 临床外科杂志, 2023, 31(4): 348-352.
[8] 庄海滨 许福生 庄美平 熊华平 谢平 朱燕华. 连续腰丛神经阻滞在髋关节置换术病人术后镇痛以及对炎症因子的影响[J]. 临床外科杂志, 2023, 31(4): 391-394.
[9] 李斌 杨冬 周常青. 阿帕替尼联合腹腔热灌注及静脉化疗治疗晚期胃癌腹膜转移转化治疗的效果[J]. 临床外科杂志, 2023, 31(3): 256-260.
[10] 刘炯 汪向飞 江斌. 腹腔镜辅助远端胃癌根治术不同Uncut Roux-en-y吻合方式对病人的疗效及对肿瘤标志物和预后的影响[J]. 临床外科杂志, 2023, 31(2): 177-180.
[11] 蒋祈 张鹏 陶凯雄. 美国国立综合癌症网络临床实践指南:胃癌(2022.V2)更新解读[J]. 临床外科杂志, 2023, 31(1): 18-20.
[12] 张再重 林晨 王烈. 联合脏器切除在进展期胃癌治疗中的意义[J]. 临床外科杂志, 2022, 30(9): 813-814.
[13] 黄昌明 林国生 黄泽宁 陆俊. 吲哚菁绿标记荧光示踪技术在腹腔镜胃癌根治术中的应用[J]. 临床外科杂志, 2022, 30(9): 815-818.
[14] 周岩冰. 机器人和4K腹腔镜在胃癌根治术中淋巴结清扫的比较[J]. 临床外科杂志, 2022, 30(9): 819-822.
[15] 蔺金军 刘俊华 慕立峰 黄占有 魏军龙 李永梅. 胃癌手术、介入化疗后存活19年一例[J]. 临床外科杂志, 2022, 30(9): 828-829.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 宫念樵. 器官捐献供肾质量评估[J]. 临床外科杂志, 2016, 24(10): 729 .
[2] 昌盛. 中国心脏死亡捐献供肾器官的维护[J]. 临床外科杂志, 2016, 24(10): 744 .
[3] 杨华;李新长;龙成美;等. 公民逝世后器官捐献供肾移植临床分析[J]. 临床外科杂志, 2016, 24(10): 747 .
[4] 石宇;刘学刚 . 冠状动脉旁路移植术后短期内应用强化他汀对患者出血风险的研究[J]. 临床外科杂志, 2016, 24(10): 750 .
[5] 李义亮;张成;克力木;等. 完全腹腔镜下远端胃癌根治术的临床体会[J]. 临床外科杂志, 2016, 24(10): 769 .
[6] 李光焰;张安平;王祥峰;等. 直肠癌切除术后吻合口狭窄14例分析[J]. 临床外科杂志, 2016, 24(10): 772 .
[7] 张忠伟;刘扬;路明. 痔上黏膜环切术治疗直肠前突所致出口梗阻型便秘的疗效观察[J]. 临床外科杂志, 2016, 24(10): 774 .
[8] 宋华;单若冰;张晋绥;等. 产前超声诊断对新生儿消化道梗阻性疾病手术治疗价值的观察[J]. 临床外科杂志, 2016, 24(10): 780 .
[9] 肖国栋;刘国辉. 跗骨窦切口联合经皮置钉技术微创治疗跟骨骨折的临床疗效分析[J]. 临床外科杂志, 2016, 24(10): 783 .
[10] 陈绍站;许勇;李婧;等. 防旋股骨近端髓内针与股骨近端解剖锁定钢板治疗转子间骨折的疗效比较[J]. 临床外科杂志, 2016, 24(10): 787 .